|
KMID : 1141720200080020083
|
|
폐쇄성폐질환
2020 Volume.8 No. 2 p.83 ~ p.85
|
|
|
Triple Therapy in COPD
|
|
Shin Sun-Hye
Park Hye-Yun
|
|
|
Abstract
|
|
|
|
Recent clinical trials of COPD patients showed the efficacy of triple therapy (ICS/LABA/LAMA) over LAMA/LABA dual bronchodilator therapy on exacerbation prevention at the expense of the increased risk of pneumonia related to ICS. According to several studies, patients with one or more exacerbations in the previous year, blood eosinophil counts ≥300 cells/μL, or history of asthma, could benefit more from triple therapy than LAMA/LABA combination therapy. However, clinicians should be aware of the potential risk of pneumonia on triple therapy.
|
|
|
KEYWORD
|
|
|
COPD, Triple therapy, Dual bronchodilator
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|